glp 1 dos and don ts of GLP-1 isn't just a medication. It's a 🚨 SAVE THIS POST FOR

Abstract Glucagon-like peptide-1 medicines are being prescribed to growing numbers of patients worldwide, for type 2 diabetes, obesity and associated comorbidities, including cardiovascular disease, peripheral artery disease and obstructive sleep apnea, and are revolutionizing public health strategies for these conditions

[22] [23] By activating GLP-1 receptors, these medications enhance insulin secretion when blood glucose levels are elevated, suppress glucagon release, slow gastric emptying, and promote satiety

It is considered unlikely to be important in the context of co-administered oral medications but may have contributed to the observed reductions in postprandial glucose

Mol Cell Biochem